GlassScriptPhysician profile
Samina Sanwari
NPI 1720425762
$1,088.82
in general payments reported to CMS, 2019-2025
10 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $173 · 2021: $14.48 · 2022: $65.52 · 2023: $256 · 2024: $304 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671 · Entertainment: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.85 |
| Entertainment | $165.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $307.04 | 2020-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $243.67 | 2023-2024 | Myday Contact Lens, Misight Contact Lens |
| Glaukos Corporation | $217.02 | 2025 | Photrexa Viscous and Photrexa |
| Bausch & Lomb Americas INC. | $126.72 | 2024 | Xiidra, Miebo |
| Alcon Vision LLC | $91.38 | 2022-2025 | Precision 1, Dailies Total1 |
| Abb Con-Cise Optical Group LLC | $37.03 | 2025 | Contact Lens |
| Allergan, INC. | $20.55 | 2022 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.48 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $13.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samina Sanwari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.